Medtronic MDT Cash Flow Statement
| FY'26 | FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|---|
| $4.84B+3.1% | $4.69B+26.6% | $3.71B-2.1% | $3.78B-25.2% | ||
| $2.96B+3.4% | $2.86B+8.1% | $2.65B-1.9% | $2.7B-0.4% | ||
| $457M+6.5% | $429M+9.2% | $393M+10.7% | $355M-1.1% | ||
| —— | -$316M+37.8% | -$508M-112% | -$240M+60.3% | ||
| $0— | $0-100% | $371M— | $0-100% | ||
| $136M+10.6% | $123M+36.7% | $90M+23.3% | $73M+25.9% | ||
| —— | —— | —— | $939M+67.7% | ||
| $46M-78.0% | $209M-46.5% | $391M-43.8% | $696M+227% | ||
| —— | —— | —— | —— | ||
| $200M-53.8% | $433M+10.7% | $391M-32.1% | $576M+20.8% | ||
| $7.33B+4.1% | $7.04B+3.8% | $6.79B+12.4% | $6.04B-17.8% | ||
| $1.9B+2.4% | $1.86B+17.1% | $1.59B+8.8% | $1.46B+6.7% | ||
| —— | —— | $211M— | —— | ||
| $8.73B+6.1% | $8.23B+6.2% | $7.75B+3.1% | $7.51B-24.0% | ||
| $8.11B-4.6% | $8.5B+14.2% | $7.44B+1.3% | $7.34B-24.2% | ||
| —— | $249M-4.6% | $261M— | —— | ||
| -$2.93B-51.5% | -$1.94B+18.1% | -$2.37B+32.3% | -$3.49B— | ||
| $3.64B+1.4% | $3.59B-2.1% | $3.67B+1.4% | $3.62B+6.9% | ||
| $1.04B-68.0% | $3.24B+51.3% | $2.14B+231% | $645M-74.6% | ||
| —— | —— | $0-100% | $5.41B— | ||
| —— | $0— | $0-100% | $6.01B— | ||
| $516M+1.6% | $508M+78.9% | $284M-7.8% | $308M-28.2% | ||
| —— | -$184M— | —— | -$409M-351% | ||
| —— | —— | —— | $0— | ||
| -$4.75B-8.9% | -$4.36B+2.0% | -$4.45B+10.3% | -$4.96B+7.0% | ||
| —— | $188M— | —— | —— | ||
| —— | $934M+461% | -$259M+88.1% | -$2.17B-1,894% | ||
| $774M+1.6% | $762M-7.7% | $826M+36.3% | $606M+12.2% | ||
| $1.94B+6.8% | $1.82B+12.1% | $1.62B+4.8% | $1.55B+55.4% | ||
| $0— | $0-100% | $371M— | $0-100% | ||
| $200M-53.8% | $433M+10.7% | $391M-32.1% | $576M+20.8% | ||
| -$314M-1.3% | -$310M+45.9% | -$573M-112% | -$270M— | ||
| $136M+10.6% | $123M+36.7% | $90M+23.3% | $73M+25.9% | ||
| —— | $249M-4.6% | $261M— | —— | ||
| $8.11B-4.6% | $8.5B+14.2% | $7.44B+1.3% | $7.34B-24.2% | ||
| $538M— | $0— | $0— | —— | ||
| —— | $508M+78.9% | $284M-7.8% | $308M-28.2% | ||
| —— | -$184M— | —— | -$409M-351% | ||
| —— | —— | —— | $0— | ||
| $1.94B+6.8% | $1.82B+12.1% | $1.62B+4.8% | $1.55B+55.4% | ||
| $5.43B+4.6% | $5.19B-0.3% | $5.2B+13.5% | $4.58B-23.4% | ||
| $5.43B+4.6% | $5.19B-0.3% | $5.2B+13.5% | $4.58B-23.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Medtronic generate?
- Medtronic (MDT) generated $7.3B in operating cash flow over the trailing twelve months.
- What is Medtronic's free cash flow?
- After $1.9B of capital expenditures, Medtronic's free cash flow was $5.4B over the trailing twelve months, up 4.7% year over year.
- Where does Medtronic's cash flow data come from?
- Every line is extracted from Medtronic's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
